Diabetes technology

Clinical evidence for high‐risk CE ‐marked medical devices for glucose management: A systematic review and meta‐analysis

Diabetes Obes MetabPublished Systematic review and meta-analysis

Pooled result · HbA1c (RCT meta-analysis)Result — go to the resultAbsolute MD −0.5 percentage points

Authors' conclusion

High-risk devices for glucose monitoring or insulin dosing, in particular AID systems, improve glucose control safely, but evidence on diabetes-related end-organ damage is lacking due to short study durations. Methodological heterogeneity highlights the need for developing standards for future pre- and post-market investigations of diabetes-specific high-risk medical devices.

Study context

Population
Studies of CE-marked high-risk devices for glucose management: Automated insulin delivery (AID) systems, implantable insulin pumps and implantable continuous glucose monitoring (CGM) devices (2009–2024)182 studies
Comparison
AID systems vs other treatments
Outcome
HbA1c (RCT meta-analysis)
Methodological detailsCoordinating Research and Evidence for Medical Devices (CORE-MD) project, interventional and observational studies, meta-analysis of randomized controlled trials (RCTs)
  • CORE-MD project
  • Interventional and observational studies
  • Meta-analysis of RCTs

Pooled result

As reported in the abstract

Absolute MD

−0.5 percentage points

Further pooled results

OutcomeMD (percentage points)
TIR for sensor glucose14 RCTs; I2 = 90%13.4

Included study characteristics

Studies on AID systems
166
Studies on insulin pumps
six
Studies on CGM devices
10
RCTs
29%
Non-randomized trials
24%
Observational studies
47%
Pre-market
18%
Had a comparator group
37%
Median (IQR) sample size
48 (28-102)
Median (IQR) age, years
34.8 (14-44.2)
Median (IQR) study duration, weeks
17.5 (12-26)

Safety

Safety assessment

Studies assessing at least one safety outcome
71%

Original publication

Clinical evidence for high‐risk CE ‐marked medical devices for glucose management: A systematic review and meta‐analysis. Diabetes Obes Metab. Published 14 August 2024. doi:10.1111/dom.15849

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.